CVS for Tobacco Smoking
University of Pennsylvania, Philadelphia, PA
Targeting 3 different conditionsCVS +1 moreN/ARecruitingLed by Emily Falk, PhDResearch Sponsored by Abramson Cancer Center at Penn MedicineEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Smoke at least 5 cigarettes a day for the past 6 months
Smoke at least 5 cigarettes a day for the past 6 months
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upfor 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]
Awards & highlights
No Placebo-Only Group
Study Summary
This trial looks at how smoking affects the brain and behavior, as well as exposure to smoking in specific environments.
Eligible Conditions
- Tobacco Smoking
- Smoking/Cigarette Smoking
- Smoking
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have been smoking at least 5 cigarettes every day for the past 6 months.
Select...
You have been smoking at least 5 cigarettes per day for the past 6 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Brain activity (measured by functional magnetic resonance imaging), in a priori regions of interest, in response to smoking vs nonsmoking cues (all 822815 participants and fMRI subset of 850796 participants)
Neural cue reactivity region definition (822815 participants and fMRI subset of 850796 participants)
Self-reported cigarette craving during the experimental manipulation period
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: CVS GroupExperimental Treatment1 Intervention
Participants visit CVS 5 times per week during the 4-week (20 store visits total) intervention period
Group II: 7-11 GroupExperimental Treatment1 Intervention
Participants visit 7-11 5 times per week during the 4-week (20 store visits total) intervention period
Group III: ControlActive Control1 Intervention
Participants are not asked to alter their behavior during the 4-week (0 store visits) intervention period
Find a site
Who is running the clinical trial?
Abramson Cancer Center at Penn MedicineLead Sponsor
369 Previous Clinical Trials
108,751 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,369 Previous Clinical Trials
41,215,085 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
1,926 Previous Clinical Trials
41,921,651 Total Patients Enrolled
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
105,401 Total Patients Enrolled
New York UniversityOTHER
214 Previous Clinical Trials
312,068 Total Patients Enrolled
Stanford UniversityOTHER
2,258 Previous Clinical Trials
17,273,460 Total Patients Enrolled
Emily Falk, PhDPrincipal Investigator
University of PennsylvaniaMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the age limit for enrolling in this experiment over 30 years old?
"This study has an age requirement of over 21 and under 65 years old for potential participants."
Answered by AI
Are there any openings for participants in this clinical experiment presently?
"Confirmed - the clinicaltrial.gov registry reveals that this trial is still seeking participants, with its initial posting occurring on December 17th 2019 and last revision taking place on July 26th 2022."
Answered by AI
How many people have been recruited for participation in this clinical trial?
"Affirmative. The information posted on clinicaltrials.gov demonstrates that this medical trial is actively recruiting patients - it was initially listed on December 17th 2019 and the data has been recently updated as of July 26th 2022. 180 participants are needed from a single site to complete the study."
Answered by AI
Could I potentially join this research effort?
"This study is actively seeking 180 participants who are between 21 and 65 years old, have smoked cigarettes on a daily basis for the past half year, own an iPhone or Android device which can be used regularly, live in Pennsylvania, Delaware or New Jersey (for remote studies) or within Philadelphia's metropolitan area (for fMRI trials), possess fluency in English language, have been fully vaccinated against COVID-19 and still smoke."
Answered by AI
Who else is applying?
What state do they live in?
New Jersey
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
0
What questions have other patients asked about this trial?
How much does this pay?
Patient
Why did patients apply to this trial?
Been waiting to find a way to stop smoking. Simple really it's a nasty habit and makes your breath bad and it's hard to breathe do it because I get stressed.
Patient
How responsive is this trial?
Typically responds via
Email
Average response time
- < 2 Days
Most responsive sites:
- University of Pennsylvania: < 48 hours
Recent research and studies